IM
Imugene
IMU.AX·ASXSydney AUFounded 201360 employees
Micro CapbiotechPublicOncology
Platform: Oncolytic CF33
Market Cap
$0.2B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (IMU.AX)
Loading IMU.AX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Mavurasimod | IMU-6040 | Phase 2 | 1 | PCSK9 | GBMAsthma | ||
| Bemacapivasertib | IMU-656 | NDA/BLA | 2 | PSMA | ACCRCC |
SEC Filings & Financial Documents
SEC filings are not available for ASX-listed companies.
Imugene trades on ASX (AU). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)